Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
J Infect
; 84(6): 834-872, 2022 06.
Article
in English
| MEDLINE | ID: covidwho-1882220
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Hepatitis C
/
Tuberculosis, Multidrug-Resistant
Limits:
Humans
Language:
English
Journal:
J Infect
Year:
2022
Document Type:
Article
Affiliation country:
J.jinf.2022.03.004
Similar
MEDLINE
...
LILACS
LIS